Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Alirocumab |
| Trade Name | |
| Synonyms | Praluent |
| Drug Descriptions |
Alirocumab is a monoclonal antibody that targets PCSK9, potentially leading to decreased tumor growth (PMID: 33177715). |
| DrugClasses | |
| CAS Registry Number | 1245916-14-6 |
| NCIT ID | C174849 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Alirocumab | Alirocumab | 0 | 0 |
| Alirocumab + Cemiplimab | Alirocumab Cemiplimab | 0 | 2 |